| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18a7d1606da2ec2ad08ae63822efb00e |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 |
| filingDate |
1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9bed76d7eb215b8467952d1114802e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254078a22ad8542cab4e8500dcda21e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d4bde5913226e3c7c24ae9446fcebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a48fb03549f076e16fa28b7c0fb42d9 |
| publicationDate |
1995-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H07138162-A |
| titleOfInvention |
Breast cancer therapeutic agent containing pyridazine derivative as active ingredient |
| abstract |
(57) [Summary] [Structure] The following general formula (I): (In the formula, R 1 is a hydrogen atom or a lower alkyl group, and R 2 is a benzyl group or a naphthylmethyl group with or without a substituent.) 3- (1H-imidazol-1-yl) pyridazine A therapeutic agent for breast cancer containing a derivative or a pharmaceutically acceptable salt thereof as an active ingredient. [Effect] A drug useful for treatment of hormone-dependent breast cancer can be provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103113349-A |
| priorityDate |
1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |